source
- BlossomHill and Latigo close IPO week with $496 million raisedBlossomHill Therapeutics, a cancer‑focused biotech, completed its initial public offering this week. Latigo, a company developing non‑opioid pain treatments, also went public at the same time. To…
- Active shooter incident forces CDC staff to shelter in place, highlighting ongoing threats to public health workersOn August 8, 2025, the author was working in an office at the Centers for Disease Control and Prevention when a series of loud bangs sounded outside. A laboratory director reported that a neighbori…